ASP2535 is primarily used in pharmaceutical research and development, particularly in the study of neurodegenerative diseases. It has shown potential in modulating specific biological pathways associated with conditions like Alzheimer’s disease and Parkinson’s disease. Researchers utilize it to investigate its effects on protein aggregation and neuroinflammation, which are key factors in these disorders. Additionally, ASP2535 is explored for its role in enhancing cognitive function and neuroprotection in preclinical studies. Its application extends to the development of novel therapeutic agents aimed at slowing or halting disease progression in neurological conditions.